Kodiak has had an amazing run over the last year but has been ranging sideways for the last couple of months. With a Bollinger breakout to the upside it could be worth a look.
Kodiak Sciences, Inc. is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD ; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD ; and KSI-401 for dry AMD .
Kodiak Sciences, Inc. is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD ; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD ; and KSI-401 for dry AMD .
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SUPERTRAIL INDICATOR: https://supertrail.io/ ✔
MY TRADINGVIEW TOUTUBE VIDEOS: https://bit.ly/3hR8re4 ✔
MY BROKER - TRADE THE BEST STOCKS GLOBALLY (65 Exchanges): https://bit.ly/3DFrDpJ ✔
MY SUPERTRAIL INDICATOR: https://supertrail.io/ ✔
MY TRADINGVIEW TOUTUBE VIDEOS: https://bit.ly/3hR8re4 ✔
MY BROKER - TRADE THE BEST STOCKS GLOBALLY (65 Exchanges): https://bit.ly/3DFrDpJ ✔